Kathleen Chandler specializes in economic and statistical analyses, discovery support, and leading teams that analyze large, complex data sets. She has experience working with counsel through all stages of litigation—both in support of testifying experts as well as during government investigations and associated settlement discussions. Her work focuses on False Claims Act (FCA) and related engagements involving drug manufacturers, medical device manufacturers, and healthcare providers which often require the analysis of large sets of Medicare or Medicaid claims data, product performance data, or IQVIA/IMS data. She also has experience in antitrust, intellectual property, and class certification matters.
MA, Applied Economics, Johns Hopkins University
BA, Economics and Spanish, University of Virginia
- In United States ex rel. Kevin N. Colquitt v. Abbott Labs., Inc., served as lead manager supporting Dr. Eric M. Gaier's expert analyses in connection with alleged off-label promotion of biliary stents.
- In United States ex rel. George v. Fresenius Medical Care Holdings, Inc., led team supporting Ben Scher's expert analysis on behalf of Fresenius Medical Care in connection with alleged pharmaceutical dosing and administration practices that violated the False Claims Act.
- Served as lead manager supporting expert analyses of Dr. Eric M. Gaier related to damages stemming from the implantation of certain models of cardiac devices that allegedly violated the FCA.
- Provided consulting support to internal and external counsel for a brand name drug manufacturer alleged to have engaged in marketing practices that violated the Food, Drug, and Cosmetic Act; the Anti-Kickback Statute; and federal and state FCA laws.
- Provided consulting support to counsel for a brand name pharmaceutical manufacturer alleged to have engaged in improper marketing practices that violated state laws.
- Supported testifying expert in a patent infringement matter related to potential biosimilar entry. Contributed to analysis of the Georgia-Pacific factors and potential damages based on the outcome of a hypothetical license negotiation.
- Supported academic expert's analysis regarding public interest and commercial success in a patent infringement matter before the International Trade Commission related to the importation of certain surgical products.
- Provided consulting support to counsel representing Humana in connection with its proposed merger with Aetna by analyzing competition on the Affordable Care Act exchanges and the extent to which Medicare Accountable Care Organizations compete with Medicare Advantage plans in providing managed care to seniors.
- Supported Dr. Richard Manning in analyzing the economics of compensated blood plasma donation, given the current supply and demand of plasma and plasma-derived medical products.
- In Legg v. Lab. Corp. of Am. Holdings, served as lead manager supporting analyses of the expert on behalf of a large clinical laboratory testing provider alleged to have violated the Fair and Accurate Credit Transactions Act (FACTA). Evaluated how data documenting the allegedly at-issue transactions informed the ascertainability of plaintiff’s proposed class and the determination of whether individual issues predominate over common issues.